President and CSO at Nano3D Biosciences, Inc. and Adjunct Assistant Professor at University of Texas Health Science Center at HoustonBiography
Dr. Glauco R. Souza is the President, CSO, and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the co-inventors and inventor of all patents related to n3D's 3D cell culturing by magnetic levitation and magnetic 3D bioprinting technologies. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. During his work at MD Anderson, he applied a multidisciplinary approach to developing nanotechnology tools for tissue targeted imaging, gene delivery, and tissue engineering. Towards the end of his post-doctoral tenure at MD Anderson, in collaboration with Rice University, the genesis of 3D cell culturing by magnetic levitation and magnetic 3D bioprinting took place. Results using these groundbreaking technologies have been reported in various high-impact scientific journals, including Nature Nanotechnology, Nature Protocols, and Nature Reviews Cancer. Now, Dr. Souza's research mission is as CSO of n3D is to advance 3D cell culturing by magnetic levitation and magnetic 3D bioprinting into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, and regenerative medicine. Recently, Glauco was an invited speaker at TEDx Houston, where he shared his thoughts and experience on resonating aspects between science, levitating cells, friendship, and sports as key ingredients for scientific discovery and the entrepreneurial process. Dr. Souza's research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), Center for Advancement of Science in Space (CASIS), and Texas Emerging Technology Fund (ETF).